Global Medical Affairs Director - Oncology

Global Medical Affairs Director - Oncology

In order to pursue Sanofi's purpose of "Chasing the miracles of science to improve people's lives", Specialty Care Medical Affairs have a vision to be the leaders in patient and scientific knowledge and insights to improve clinical care. We do this by generating and curating the most critical patient and scientific evidence and by being highly credible partners shaping scientific exchange and engagement. We serve as key strategic partners for commercial, regulatory, R&D, market access and external affairs to develop and launch first in class and best in class therapeutic solutions that address highest unmet needs.

Sanofi is recruiting a new Director in Global Medical Affairs (GMA) based in Cambridge, MA, to support oncology evidence generation. It is a highly visible role to all levels within the company due to the optimism for therapies based on the impact they will have on patients. Essential to success is an outstanding partnership with Countries, Clinical Development and Commercial to maximize the value proposition. Externally, the role assists health care professionals and payers to optimize patient care and treatment outcomes through evidence-based decisions.

We are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases and blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.

Main Responsibilities

• Expert internal cross-functional leadership throughout the GPT-GBT continuum to advance the development of assigned assets, assure successful launches, and follow throughout their life cycle.
• Driving Medical Affairs activities for oncology, specifically on clinical evidence generation and implementation therapies.
• Build trust with Global external stakeholders to advance their understanding of the therapeutic area and evolve the treatment landscapes for pipeline assets or marketed products.
• Co-create the IEGP strategy with Medical Evidence Generation Lead and other evidence generation-related functions for the subcutaneous formulation : Clinical Study Unit (CSU), Real World Evidence (RWE), Health Economics Outcomes Research (HEVA), Medical Operations and Effectiveness (MO&E) and country teams.
• Oversee insight generation plan and input to the assigned assets overall medical strategy.
• Provide strategic input to Scientific Communications teams to plan and execute evidence dissemination and medical education plans.
• Lead the Integrated Patient Journey (IPJ) strategy for subcut globally with Key Markets.
• Oversee the design of key medical programs / initiatives to drive the therapeutic value of the subcutaneous formulation and address unmet medical needs (i.e., MAPs, Diagnostic support programs, CSRs, etc)
• Oversee medical tactics and clinical study budgets planning and execution to assure prioritization, alignment with strategy and smart execution.

Experience

Leadership Skills

Technical Skills

Why Choose Us